Literature DB >> 33604344

Epidemiological Variations in the Global Burden of Psoriasis, an Analysis With Trends From 1990 to 2017.

Chen Peng1,2, Xin Xu1,2, Wenjuan Chen1,2, Xingzi Li1,2, Xuemei Yi1,2, Yangfeng Ding1,2, Ning Yu1,2, Jiajing Lu1,2.   

Abstract

Background: Although there have been many epidemiological studies, research focusing on psoriasis' health burden on a global scale is still lacking. Trends and variations in the global health burden of psoriasis are evaluated by time, age, gender, geographical location, and socioeconomic status, using disability-adjusted life years (DALYs) from the Global Burden of Disease Study.
Methods: The health burden of psoriasis was evaluated by DALYs, which combined years lost to disability (a morbidity component) with years of life lost (a mortality component). The global and national DALYs number, crude DALYs rate, and age-standardized DALYs rate were obtained from the GBD 2017 study database. The corresponding human development index (HDI) was collected from the United Nations Development Programme.
Results: From 1990 to 2017, the DALYs number and crude DALYs rate due to psoriasis increased by 73 and 22%, respectively. In comparison, the age-standardized DALYs rate showed a slight increase. Patients in the age range of 65-69 years bear a more significant psoriasis burden. Both males and females showed an increasing trend in burden caused by psoriasis over the past 27 years, with females bearing a more significant psoriasis burden than males. The health burden of psoriasis was substantially unequal in geography with a Gini coefficient of 0.27. The concentration indexes indicated a socioeconomic associated inequality in psoriasis burden with values of 0.22, accounting for 48.64% variance across countries (R2 = 0.4864, p < 0.001). Between-nation inequality in the distribution of psoriasis burden continued to decline throughout the past 27 years. Gini coefficients of psoriasis burden decreased from 0.280 in 1990 to 0.265 in 2017. The concentration indexes indicated the same trend with 0.236 in the 1990s and 0.223 in 2017. Conclusions: Global health progress in psoriasis together with inequality in the past few decades. Although the inequality of psoriasis burden has shown some improvement during the past 27 years, disparities still exist in age, gender, geographical location, as well as socioeconomic status. The findings of this study highlight the global importance of psoriasis and is important in policy planning for psoriasis services on a global scale.
Copyright © 2021 Peng, Xu, Chen, Li, Yi, Ding, Yu and Lu.

Entities:  

Keywords:  epidemiology; gender inequality; geographic and socioeconomic disparity; global burden; psoriasis

Year:  2021        PMID: 33604344      PMCID: PMC7884455          DOI: 10.3389/fmed.2021.585634

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  20 in total

Review 1.  Measuring inequalities in health: what do we know? What do we need to know?

Authors:  Joan Costa-Font; Cristina Hernández-Quevedo
Journal:  Health Policy       Date:  2012-05-18       Impact factor: 2.980

2.  A welfare economics foundation for health inequality measurement.

Authors:  Han Bleichrodt; Eddy van Doorslaer
Journal:  J Health Econ       Date:  2006-02-08       Impact factor: 3.883

Review 3.  Assessing burden of disease as disability adjusted life years in life cycle assessment.

Authors:  Yumi Kobayashi; Greg M Peters; Nicholas J Ashbolt; Sean Shiels; Stuart J Khan
Journal:  Sci Total Environ       Date:  2015-05-29       Impact factor: 7.963

Review 4.  Evaluating the economic burden of psoriasis in the United States.

Authors:  Jacqueline Vanderpuye-Orgle; Yang Zhao; Jackie Lu; Anshu Shrestha; Alison Sexton; Seth Seabury; Mark Lebwohl
Journal:  J Am Acad Dermatol       Date:  2015-04-14       Impact factor: 11.527

5.  The impact of age on psoriasis health care in Germany.

Authors:  A Trettel; C Spehr; A Körber; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-03-09       Impact factor: 6.166

6.  Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis.

Authors:  Marlena Hawro; Marcus Maurer; Karsten Weller; Romuald Maleszka; Anna Zalewska-Janowska; Andrzej Kaszuba; Zofia Gerlicz-Kowalczuk; Tomasz Hawro
Journal:  J Am Acad Dermatol       Date:  2017-01-06       Impact factor: 11.527

7.  Quantifying the burden of disease: the technical basis for disability-adjusted life years.

Authors:  C J Murray
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 8.  Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.

Authors:  Jillian Frieder; Dario Kivelevitch; Alan Menter
Journal:  Ther Deliv       Date:  2017-06-29

9.  Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis.

Authors:  Jochen M Schmitt; Daniel E Ford
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

10.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

View more
  2 in total

1.  Inequalities in the Global Burden of Chronic Kidney Disease Due to Type 2 Diabetes Mellitus: An Analysis of Trends from 1990 to 2019.

Authors:  Nóra Kovács; Attila Nagy; Viktor Dombrádi; Klára Bíró
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

2.  Meta-Analysis of the Efficacy and Safety of Interleukin-23-Targeted Drugs in the Treatment of Moderate-to-Severe Psoriasis.

Authors:  Teng Zhu; Lin Ma
Journal:  Contrast Media Mol Imaging       Date:  2022-06-28       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.